Nalaganje...
New strategies for applying targeted therapies to adrenocortical carcinoma
Adrenocortical carcinoma (ACC) is a rare, aggressive, and frequently deadly cancer. Up to 75% of all patients will eventually develop metastatic disease, and our current medical therapies for ACC provide limited – if any – survival benefit. These statistics highlight a crucial need for novel approac...
Shranjeno v:
| izdano v: | Curr Opin Endocr Metab Res |
|---|---|
| Main Authors: | , , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
2019
|
| Teme: | |
| Online dostop: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7133705/ https://ncbi.nlm.nih.gov/pubmed/32258822 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.coemr.2019.07.006 |
| Oznake: |
Označite
Brez oznak, prvi označite!
|